Company · CIK 0002079109 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Veraxa Biotech AG - Post de-SPAC · VRXA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 PForm 4 → | Aug 31, 4:10 pm EDT | Oliver Rolf BaumannDirector | 50,000 | $1.50 | $75,000 | 5,773,618 | +0.87% | |
| Aug 27, 2026 PForm 4 → | Aug 31, 4:10 pm EDT | Christoph Rudiger AntzChief Executive Officer, Director | 5,000 | $1.53 | $7,650 | 5,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.